Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS)
$
16. 51
-0.22
-1.315%
$
2.14B Market Cap
- P/E Ratio
- Div Yield
736,075 Volume
-0.52 Eps
$ 16.73
Previous Close
Add Transaction
Day Range
16.35 16.81
Year Range
11.3 19.25
Want to track AUPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Aurinia Pharmaceuticals Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
35,871 $365,507.78 $595,817.31 $230,309.53 63.01%
William Staveacre
William Staveacre Aster Capital Management (DIFC) Ltd.
23,148 $392,821.56 $388,076.22 -$4,745.34 -1.21%
Stephen A. Greco
Stephen A. Greco Pandora Wealth Inc.
75 $603 $1,245 $642 106.47%
Grant Reeves
Grant Reeves CVFG LLC
68,500 $1.02M $1.13M $115,904.98 11.39%
BM
Berkeley Meredith Hughes Financial Services LLC
2 $32 $33.46 $1.46 4.56%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
966 $16,393 $15,910.02 -$482.98 -2.95%
DWM
Dogwood Wealth Management LLC Dogwood Wealth Management LLC
89 $1,319 $1,468.5 $149.5 11.33%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
2,815 $26,743.37 $46,334.9 $19,591.53 73.26%